| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 01/03/2003 | WO2003000663A1 5-ht receptor ligands and uses thereof |
| 01/03/2003 | WO2003000657A1 Diamine derivatives |
| 01/03/2003 | WO2003000267A1 Amino nicotinate derivatives as glucokinase (glk) modulators |
| 01/03/2003 | WO2003000262A1 Vinyl phenyl derivatives as glk activators |
| 01/03/2003 | WO2003000261A1 Use of bicyclo compounds for treating alzheimer's disease |
| 01/03/2003 | WO2003000260A1 Thiazolyl amides and their use as antiviral drugs |
| 01/03/2003 | WO2003000259A1 Topical application of thiazolyl amides |
| 01/03/2003 | WO2003000256A1 Substituted oxazolidinones for combinational therapy |
| 01/03/2003 | WO2003000250A1 3-fluoro-pyrrolidines as antidiabetic agents |
| 01/03/2003 | WO2003000180A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | WO2002083667A3 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/03/2003 | WO2002083656A3 5-membered heterocycles, preparation and use thereof as mao inhibitors and lipid peroxidation inhibitors, preparation thereof and use thereof as medicaments |
| 01/03/2003 | WO2002064577A3 Method for preparing compounds derived from thiazolidinedione, oxazolidinedione |
| 01/03/2003 | WO2002046170A8 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 01/03/2003 | WO2002020531A3 Method for producing anellated tetrahydro-[1h]-triazoles |
| 01/03/2003 | WO2001083800A8 Heterologous production of polyketides |
| 01/03/2003 | CA2455292A1 5-ht receptor ligands and uses thereof |
| 01/03/2003 | CA2451664A1 Use of bicyclo compounds for treating alzheimer's disease |
| 01/03/2003 | CA2451543A1 Thiazolyl amides and their use as antiviral drugs |
| 01/03/2003 | CA2451249A1 Amino nicotinate derivatives as glucokinase (glk) modulators |
| 01/03/2003 | CA2450579A1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | CA2450562A1 Tyrosine kinase inhibitors |
| 01/03/2003 | CA2450550A1 Spiropiperidine compounds as ligands for orl-1 receptor |
| 01/03/2003 | CA2450491A1 5-ht receptor ligands and uses thereof |
| 01/03/2003 | CA2450480A1 Oxytocin agonists |
| 01/03/2003 | CA2449441A1 3-fluoro-pyrrolidines as antidiabetic agents |
| 01/02/2003 | WO2002002529A1 Bicyclic lactams and sulfonamides with 5-ht1a-affinity and use thereof for preventing and treating cerebral ischaemia |
| 01/02/2003 | US20030004351 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 01/02/2003 | US20030004344 Thrombin or factor Xa inhibitors |
| 01/02/2003 | US20030004338 Antitumor, anticancer agents |
| 01/02/2003 | US20030004212 Cyclohexylamine derivatives as subtype selective N-Methyl-D-Aspartate antagonists |
| 01/02/2003 | US20030004195 Reducing pressure in eye |
| 01/02/2003 | US20030004194 Method for treating fibrotic diseases or other indications VI |
| 01/02/2003 | US20030004185 Viricides, organ transplants, antiarthritic agents |
| 01/02/2003 | US20030004181 Disubstituted bicyclic heterocycles, the preparation thereof, and their use as pharmaceutical compositions |
| 01/02/2003 | US20030004174 Antiinflammatory agents, anticancer agents, antihistamines, central nervous system disorders |
| 01/02/2003 | US20030004164 Anticancer agents; autoimmune diseases |
| 01/02/2003 | US20030004162 Antidiabetic agents; dietetics |
| 01/02/2003 | US20030004161 Anticancer agents; autoimmune diseases |
| 01/02/2003 | US20030004137 Muscle relaxants, controlling immunology, strokes, antidiabetic agents |
| 01/02/2003 | US20030003396 Reflection, protective or covering layers which can be written on or read by blue, red or infrared light |
| 01/02/2003 | EP1270557A1 Ethylenediamine derivatives |
| 01/02/2003 | EP1268484A1 Condensed imidazoles as histamine h3 receptor ligands |
| 01/02/2003 | EP1268475A1 Novel benzosultam oxazolidinone antibacterial agents |
| 01/02/2003 | EP1268474A2 Substituted 1,3-thiazole compounds, their production and use |
| 01/02/2003 | EP1268467A1 Heteroaromatic compounds having two-photon absorption activity |
| 01/02/2003 | EP1268466A1 Decahydro-isoquinolines |
| 01/02/2003 | EP1268465A1 Triarylimidazole derivatives as cytokine inhibitors |
| 01/02/2003 | EP1268452A1 BICYCLIC SULFONYL AMINO INHIBITORS OF FACTOR Xa |
| 01/02/2003 | EP1268444A1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrmidines as antineoplastic agents |
| 01/02/2003 | EP1268443A1 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| 01/02/2003 | EP1268431A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| 01/02/2003 | EP1268428A2 Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade |
| 01/02/2003 | EP1268419A1 Pyrrolidine derivatives useful as bax inhibitors |
| 01/02/2003 | EP1268418A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
| 01/02/2003 | EP1268412A1 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 01/02/2003 | EP1073654A4 2,3-olefinic epothilone derivatives |
| 01/02/2003 | EP1073648A4 12,13-modified epothilone derivatives |
| 01/02/2003 | EP1073647A4 12,13-cyclopropane epothilone derivatives |
| 01/02/2003 | CA2414726A1 Bicyclic lactams and sulfonamides with 5-ht1a-affinity and use thereof for preventing and treating cerebral ischaemia |
| 01/01/2003 | CN1388804A Amino acid-N-carboxy anhydrides having substitent at nitrogen |
| 01/01/2003 | CN1387849A Use of thiazolidinedione for preventing or retaining non-insulin-dependent diabets mellitus (NIDDM) attack |
| 01/01/2003 | CN1387848A Use of thiazolidinedione for preventing or retaining non-insulin-dependent diabets mellitus (NIDDM) attack |
| 01/01/2003 | CN1097587C Dihydrobenzofuran and related compound used as anti-inflammatory agent |
| 12/31/2002 | US6500959 Pyrrolidine derivatives and processes for preparing same |
| 12/31/2002 | US6500950 Benzylidenepyrazolones, their preparation and use |
| 12/31/2002 | US6500948 Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof |
| 12/31/2002 | US6500855 Nitrogen containing aromatic heterocycles with ortho-substituted p1 groups; anticoagulants |
| 12/31/2002 | US6500845 Activating cytokine release using immunosuppressants such as 2-(3-methyl-2-oxo-piperidin-3-yl)-benzo(d)isoselenazol-3-one, racemic mixtures or isomers having dimensional stability, prepared in the presence of reducing agent |
| 12/31/2002 | US6500842 N-((4-chlorophenyl)methyl)-8-hydroxy-7-quinolinecarboxamide administered as viricides against herpes virus |
| 12/31/2002 | US6500832 Administering enzyme inhibitors as viricides for prophylaxis of viral diseases such as aquired immune deficiency syndrome |
| 12/31/2002 | US6500822 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists |
| 12/31/2002 | US6500818 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 12/31/2002 | US6500817 Thiazolyl urea derivatives and their utilization as antiviral agents |
| 12/27/2002 | WO2002102791A1 Pyrrolidine bicyclic compounds |
| 12/27/2002 | WO2002102782A2 QUINAZOLINE DERIVATIVES which PROMOTE THE RELEASE OF PARATHYROID_HORMONE |
| 12/27/2002 | WO2002102780A1 Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient |
| 12/27/2002 | WO2002102778A1 Phenylpyridine carbonyl piperazine derivative |
| 12/27/2002 | WO2002102359A2 Alkylidene pyrazolidinedione derivatives and use for treating diabetes and obesity |
| 12/27/2002 | WO2002102315A2 QUINAZOLINE AND PYRIDO[2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7 |
| 12/27/2002 | WO2002102314A2 Purine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | WO2002102313A2 Pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | CA2450936A1 Purine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | CA2450934A1 Pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | CA2450724A1 Quinazoline and pyrido¬2,3-d|pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | CA2449212A1 Alkylidene pyrazolidinedione derivatives and use for treating diabetes and obesity |
| 12/27/2002 | CA2448298A1 Phenylpyridine carbonyl piperazine derivative |
| 12/27/2002 | CA2446931A1 Pyrrolidine bicyclic compounds |
| 12/26/2002 | US20020198250 Pyrrolidine derivative hair growth compositions and uses |
| 12/26/2002 | US20020198243 Cyclizing the tert-butyl-thiourea derivative to form the end product |
| 12/26/2002 | US20020198236 Small organic molecule regulators of cell proliferation |
| 12/26/2002 | US20020198213 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 12/26/2002 | US20020198200 Alpha-acyl- and alpha-heteroatom-substituted benzene acetamide glucokinase activators |
| 12/26/2002 | US20020198197 Metabotropic glutamate receptor agonist for treatment or prevention of acute and/or chronic neurological disorders |
| 12/26/2002 | US20020198195 New oxybenzamide derivatives useful for inhibiting factor Xa or VIIa |
| 12/25/2002 | CN1387529A N-substd. carbamoyloxyalkyl-azolium derivs. |
| 12/25/2002 | CN1387528A Heterocyclic substd, pyrazolones |
| 12/25/2002 | CN1387519A 2-imino-1,3-thiazine derivs. |
| 12/25/2002 | CN1387516A Substd. 5-benzyl-2,4-diaminopyrimidines |
| 12/25/2002 | CN1387514A Aromatic sulfone hydroxamic acid metalloprotease inhibitor |